DK1023265T3 - Azetidinonderivater til behandlingen af HCMV infektioner - Google Patents

Azetidinonderivater til behandlingen af HCMV infektioner

Info

Publication number
DK1023265T3
DK1023265T3 DK98947257T DK98947257T DK1023265T3 DK 1023265 T3 DK1023265 T3 DK 1023265T3 DK 98947257 T DK98947257 T DK 98947257T DK 98947257 T DK98947257 T DK 98947257T DK 1023265 T3 DK1023265 T3 DK 1023265T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
phenyl
het
optionally substituted
alkyl
Prior art date
Application number
DK98947257T
Other languages
Danish (da)
English (en)
Inventor
Christiane Yoakim
Catherine Chabot
Robert Deziel
Stephen Kawai
Willian W Ogilvie
Jeffrey O'meara
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of DK1023265T3 publication Critical patent/DK1023265T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98947257T 1997-10-07 1998-10-06 Azetidinonderivater til behandlingen af HCMV infektioner DK1023265T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6154897P 1997-10-07 1997-10-07
PCT/CA1998/000954 WO1999018073A1 (fr) 1997-10-07 1998-10-06 Derives d'azetidinone pour le traitement d'infections hcmv

Publications (1)

Publication Number Publication Date
DK1023265T3 true DK1023265T3 (da) 2003-02-24

Family

ID=22036473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98947257T DK1023265T3 (da) 1997-10-07 1998-10-06 Azetidinonderivater til behandlingen af HCMV infektioner

Country Status (10)

Country Link
US (1) US6211170B1 (fr)
EP (1) EP1023265B1 (fr)
JP (1) JP2001519330A (fr)
AT (1) ATE231124T1 (fr)
AU (1) AU9426198A (fr)
CA (1) CA2301967C (fr)
DE (1) DE69810800T2 (fr)
DK (1) DK1023265T3 (fr)
ES (1) ES2187064T3 (fr)
WO (1) WO1999018073A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005274927B2 (en) 2004-07-15 2011-11-03 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0608899D0 (en) * 2006-05-05 2006-06-14 Leuven K U Res & Dev Novel viral replication inhibitors
WO2009045382A1 (fr) * 2007-10-04 2009-04-09 Merck & Co., Inc. Dérivé d'arylsulfone substituée comme bloqueurs des canaux calciques
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8802696B2 (en) * 2009-05-12 2014-08-12 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
WO2010132487A1 (fr) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company Formes cristallines de (s)-7-([1,2,4]triazolo[1,5-a] pyridin -6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline et leurs utilisations
CN102458123A (zh) * 2009-05-12 2012-05-16 阿尔巴尼分子研究公司 芳基、杂芳基和杂环取代的四氢异喹啉及其用途
US9216180B2 (en) 2012-10-02 2015-12-22 New York University Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
IL89835A0 (en) * 1988-04-11 1989-12-15 Merck & Co Inc Substituted azetidinones,their preparation and pharmaceutical compositions containing them
EP0377549B1 (fr) 1989-01-03 1998-12-09 Marcos Y. Kleinerman Télédétection des variables physiques par des systèmes à fibre optique
US5104862A (en) 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5100880A (en) 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
NZ282488A (en) * 1994-03-23 1999-09-29 Tokyo Tanabe Co Therapeutic or prophylactic medicament for viral disease containing antileukoprotease (serine protease inhibitor)

Also Published As

Publication number Publication date
US6211170B1 (en) 2001-04-03
ES2187064T3 (es) 2003-05-16
WO1999018073A1 (fr) 1999-04-15
JP2001519330A (ja) 2001-10-23
AU9426198A (en) 1999-04-27
DE69810800D1 (de) 2003-02-20
ATE231124T1 (de) 2003-02-15
CA2301967A1 (fr) 1999-04-15
DE69810800T2 (de) 2003-09-18
CA2301967C (fr) 2005-05-17
EP1023265A1 (fr) 2000-08-02
EP1023265B1 (fr) 2003-01-15

Similar Documents

Publication Publication Date Title
ATE222894T1 (de) Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
ES2141262T3 (es) Amidas ciclicas fungicidas.
DK1021405T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
MY104652A (en) A spiro compound
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
DE60005504D1 (de) Chinolinderivate als mek enzym-inhibitoren
NO975901D0 (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
ATE147394T1 (de) 4-(1'-oxocyclohex-2'-yl)azetidin-2-on-derivate
SE0201937D0 (sv) Therapeutic agents
ATE231124T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
FI925871A0 (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
DE60239170D1 (de) Bicyclische Verbindungen
ATE324113T1 (de) Verwendung von 2,6-dialkyl-4-silyl-phenol derivaten zur behandlung von xanthom
DK1021404T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
NZ336368A (en) Substituted pyrazole-3-yl benzazoles and their use as herbicides
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
MX9708422A (es) Esteres de carbapenemas.
NZ336876A (en) Process for preparation of 4-H-4-oxo-quinolizine-3-carboxylic acid derivatives
CO5261568A1 (es) Oxazolidinonas derivadas de sultamas o sultonas